Preoperative devascularization of advanced renal adenocarcinoma using a sclerosing agent

Ronald Peter Konchanin, K. J. Cho, H. B. Grossman

Research output: Contribution to journalArticle

Abstract

Sodium tetradecyl sulfate is a sclerosing agent used currently as therapy for varicose veins. Animal experiments have demonstrated this drug to be a useful agent for renal tissue destruction. We have used sodium tetradecyl sulfate with or without steel coils for preoperative renal devascularization in 6 patients with advanced renal adenocarcinoma. In all patients sodium tetradecyl sulfate effectively caused renal infarction and was tolerated well. No complications were associated with the use of this agent. Sodium tetradecyl sulfate is an efficient fluid embolic agent that can be a useful adjunct to nephrectomy in selected cases.

Original languageEnglish (US)
Pages (from-to)199-201
Number of pages3
JournalJournal of Urology
Volume137
Issue number2
DOIs
StatePublished - Jan 1 1987

Fingerprint

Sodium Tetradecyl Sulfate
Sclerosing Solutions
Renal Cell Carcinoma
Renal Agents
Kidney
Steel
Varicose Veins
Nephrectomy
Infarction
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Urology

Cite this

Preoperative devascularization of advanced renal adenocarcinoma using a sclerosing agent. / Konchanin, Ronald Peter; Cho, K. J.; Grossman, H. B.

In: Journal of Urology, Vol. 137, No. 2, 01.01.1987, p. 199-201.

Research output: Contribution to journalArticle

@article{ac95fc8bbfa24b7cb0323bab6495b422,
title = "Preoperative devascularization of advanced renal adenocarcinoma using a sclerosing agent",
abstract = "Sodium tetradecyl sulfate is a sclerosing agent used currently as therapy for varicose veins. Animal experiments have demonstrated this drug to be a useful agent for renal tissue destruction. We have used sodium tetradecyl sulfate with or without steel coils for preoperative renal devascularization in 6 patients with advanced renal adenocarcinoma. In all patients sodium tetradecyl sulfate effectively caused renal infarction and was tolerated well. No complications were associated with the use of this agent. Sodium tetradecyl sulfate is an efficient fluid embolic agent that can be a useful adjunct to nephrectomy in selected cases.",
author = "Konchanin, {Ronald Peter} and Cho, {K. J.} and Grossman, {H. B.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(17)43949-8",
language = "English (US)",
volume = "137",
pages = "199--201",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Preoperative devascularization of advanced renal adenocarcinoma using a sclerosing agent

AU - Konchanin, Ronald Peter

AU - Cho, K. J.

AU - Grossman, H. B.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Sodium tetradecyl sulfate is a sclerosing agent used currently as therapy for varicose veins. Animal experiments have demonstrated this drug to be a useful agent for renal tissue destruction. We have used sodium tetradecyl sulfate with or without steel coils for preoperative renal devascularization in 6 patients with advanced renal adenocarcinoma. In all patients sodium tetradecyl sulfate effectively caused renal infarction and was tolerated well. No complications were associated with the use of this agent. Sodium tetradecyl sulfate is an efficient fluid embolic agent that can be a useful adjunct to nephrectomy in selected cases.

AB - Sodium tetradecyl sulfate is a sclerosing agent used currently as therapy for varicose veins. Animal experiments have demonstrated this drug to be a useful agent for renal tissue destruction. We have used sodium tetradecyl sulfate with or without steel coils for preoperative renal devascularization in 6 patients with advanced renal adenocarcinoma. In all patients sodium tetradecyl sulfate effectively caused renal infarction and was tolerated well. No complications were associated with the use of this agent. Sodium tetradecyl sulfate is an efficient fluid embolic agent that can be a useful adjunct to nephrectomy in selected cases.

UR - http://www.scopus.com/inward/record.url?scp=0023127149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023127149&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(17)43949-8

DO - 10.1016/S0022-5347(17)43949-8

M3 - Article

C2 - 3806803

AN - SCOPUS:0023127149

VL - 137

SP - 199

EP - 201

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -